Showing results (941-950 of 1,041) with videos related to
Sort By:
Pageof 105
Journal of Psychiatric Research|June 27, 2021
NeuroPharm study: EEG wakefulness regulation as a biomarker in MDDCheng-Teng Ip, Melanie Ganz, Vibeke H Dam, et al.Journal of Affective Disorders|February 23, 2026
Readiness to change: Exploring clinical, cognitive and neural predictors of treatment efficacy following virtual reality-based cognitive remediation in mood and schizophrenia spectrum disordersAndreas Elleby Jespersen, Laura Montejo, Viktoria Damgaard, et al.Bipolar Disorders|August 14, 2025
Longitudinal Trajectory of Cognition, Brain Morphometry, and Brain Predicted Age in Unaffected First-Degree Relatives of Patients With Bipolar DisorderHanne Lie Kjærstad, Julian Macoveanu, Alexander Tobias Ysbæk-Nielsen, et al.Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|April 17, 2020
Quantitative Inflammation Assessment for Crohn Disease Using Ultrasensitive Ultrasound Microvessel Imaging: A Pilot StudyPing Gong, Pengfei Song, Amy B Kolbe, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|March 9, 2019
Correction: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levelsMartin K Madsen, Patrick M Fisher, Daniel Burmester, et al.European Journal of Neurology|April 20, 2019
Molecular imaging of neuroinflammation in patients after mild traumatic brain injury: a longitudinal 123 I-CLINDE single photon emission computed tomography studyS E Ebert, P Jensen, B Ozenne, et al.Archives of General Psychiatry|January 6, 2010
Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophreniaHans Rasmussen, David Erritzoe, Rune Andersen, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 28, 2019
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levelsMartin K Madsen, Patrick M Fisher, Daniel Burmester, et al.Human Brain Mapping|September 16, 2014
BDNF Val66met and 5-HTTLPR polymorphisms predict a human in vivo marker for brain serotonin levelsPatrick M Fisher, Klaus K Holst, Dea Adamsen, et al.Neuroimage|February 27, 2016
Different partial volume correction methods lead to different conclusions: An (18)F-FDG-PET study of agingDouglas N Greve, David H Salat, Spencer L Bowen, et al.Pageof 105